Details of the Probe-central Interaction Altas
General Information of Experiment
Probe Name | DFG-out-3 | Probe Info | ||||
---|---|---|---|---|---|---|
Probe concentration | 1 uM | |||||
Criteria | Quantification: Probe vs (Probe+Competitor) | |||||
Quantitative Method |
SILAC
|
|||||
Competitor Name | Ranjitkar_cp1 | Competitor Info | ||||
Competitor Concentration | 10 uM | |||||
In Vivo Experiment Model | Model Type |
|
Living cell | |||
Derived Tissue |
|
Skin | ||||
Disease Model | Skin squamous cell carcinoma [ICD-11:2C31] | |||||
Model Name | Human skin squamous cell carcinoma cells (A431) | |||||
Interaction Altas of This Experiment [1]
Enzyme
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP03477 | Ephrin type-B receptor 2 (EPHB2) | 67.0 | ||||
LDTP04629 | Ephrin type-B receptor 3 (EPHB3) | 32.0 | ||||
LDTP03474 | Ephrin type-A receptor 2 (EPHA2) | 9.4 | ||||
LDTP02231 | Tyrosine-protein kinase Yes (YES1) | 5.5 | ||||
LDTP02638 | Proto-oncogene tyrosine-protein kinase Src (SRC) | 4.1 | ||||
LDTP00497 | Cyclin-G-associated kinase (GAK) | 3.5 | ||||
LDTP10201 | Atypical kinase COQ8B, mitochondrial (COQ8B) | 2.7 |